Magnetic resonance imaging (MRI) and fast field-cycling (FFC) NMR are both well-
developed methods. The combination of these techniques, namely fast field-cycling …

The fibrinolytic system generates plasmin, which dissolves fibrin in haemostatic plugs and in
thrombi. It is often regarded simply as a secondary phenomenon responsive to the …

The distribution of PAI‐1 in the plasma and platelets of normal individuals and of patients
with platelet abnormalities was studied. An ELISA, capable of measuring PAI‐1 in plasma at …

Plasminogen activator inhibitor 2 (PAI-2) is a major product of activated human monocytes.
Here we show that monocytes inhibited u-PA-but not t-PA-mediated fibrinolysis, by secreting …

Several microbial pathogens augment their invasive potential by binding and activating
human plasminogen to generate the proteolytic enzyme plasmin. Yeast cells and cell wall …

Extracts of human tissue were analysed for plasminogen activator inhibitor (PAI-1) antigen
and activity. PAI-1 was localised in tissues by an immunochemical method, using …

Factor XIII (FXIII) generates fibrin-fibrin and fibrin-inhibitor cross-links. Our flow model, which
is sensitive to cross-linking, was used to assess the effects of FXIII and the fibrinolytic …

Factor XIII (FXIII) stabilizes thrombi against fibrinolysis by cross-linking α2-antiplasmin
(α2AP) to fibrin. Cellular FXIII (FXIII-A) is abundant in platelets, but the extracellular functions …

The enzyme methylglyoxal synthase (MGS) was partially purified from Escherichia coli
extracts, and the amino‐terminal sequence of candidate proteins was determined, based on …

Summary PAI‐1 and α 2‐antiplasmin (α 2 AP) are the principal direct inhibitors of fibrinolytic
proteases. Thrombin activatable fibrinolysis inhibitor (TAFI), a plasma procarboxypeptidase …